Friday 6 November 2026
Export MYO’s income statement to Excel — free account
Myomo, Inc.
MYO Healthcare Medical Devices
Myomo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.9 million, up 25.7% from fiscal 2024.
- Revenue
- +21.3%
- EPS
- +18.2%
- Free cash flow
- +80.0%
- Total debt
- +199.5%
Quarter to June 2026, against a year earlier
1.22
0.03
+2.52%
Follow MYO
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 2 | 2 | 1 |
| (100.51%) | (86.24%) | (98.53%) | (123.76%) | ||
| (47.71%) | (38.51%) | (38.95%) | (39.20%) | ||
ROIC |
(122.21%) | (212.70%) | (207.35%) | (167.90%) | |
Return on Tangible Assets |
(68.84%) | (72.69%) | (81.65%) | (91.23%) | |
Average Days of Receivables |
46.39 | 36.53 | 42.73 | 41.73 | |
Free Cash Flow per Share |
(0.33) | (0.43) | (0.41) | (0.21) | |
Free Cash Flow |
(13.85) | (17.84) | (17.19) | (9.09) | |
Capital Expenditures |
(3.84) | (3.33) | (3.16) | (1.98) | |
| Other line items | |||||
Cash ROIC |
(44.41%) | (43.50%) | (48.25%) | (29.07%) | |
Accounts Receivable Turnover |
9.23 | 10.33 | 8.69 | 7.21 | |
Accounts Payable Turnover |
2.12 | 1.89 | 1.61 | 1.73 | |
Inventory Turnover |
3.96 | 4.46 | 4.06 | 3.75 | |
Average Days of Payables |
174.80 | 151.30 | 182.66 | 200.36 | |
Days of Inventory on Hand |
95.56 | 81.19 | 92.32 | 84.49 | |
Tax Rate |
0.04 | 0.03 | 0.04 | 0.03 | |
Research and Development Expense of Revenue |
16.52% | 16.97% | 16.45% | 15.02% | |
Selling, General and Administrative Expense of Revenue |
78.56% | 83.92% | 83.58% | 80.39% | |
Share Based Compensation of Revenue |
4.42% | 5.09% | 5.20% | 6.45% | |
Interest Coverage |
— | — | (26.57) | — | |
Operating CF/Net income |
0.83 | 0.93 | 0.93 | 0.49 | |
Depreciation/Fixed assets |
0.51 | 1.11 | 1.20 | 1.53 | |
Capex/Depreciation |
(2.04) | (1.36) | (1.18) | (0.65) | |
Revenue per Share |
0.99 | 0.98 | 0.97 | 1.01 | |
Operating CF per Share |
(0.24) | (0.35) | (0.33) | (0.17) | |
Capex per Share |
(0.09) | (0.08) | (0.07) | (0.05) | |
Capex to Sales |
0.09 | 0.08 | 0.08 | 0.05 |
Columns are period end dates · fundamentals updated 26 Oct 2026